Tandem Diabetes Care (TNDM) Other financing activities (2015 - 2024)

Tandem Diabetes Care (TNDM) has reported Other financing activities for 9 consecutive years, with $183000.0 the latest figure, recorded in Q1 2024.

• For the quarter ending Q1 2024, Other financing activities changed N/A year-over-year to $183000.0; the trailing twelve-month figure through Dec 2024 stood at $183000.0 (up 357.75% YoY), and the FY2024 full-year result was $183000.0, up 357.75% from the prior year.
• Other financing activities grew to $183000.0 in Q1 2024 per TNDM's latest filing, from -$71000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $2.0 million in Q2 2020 and bottomed at -$405000.0 in Q3 2022.
• Historically, Other financing activities has averaged $235538.5 across 5 years, with a median of $16000.0 in 2022.
• The widest YoY moves for Other financing activities: up 8400.0% in 2022, down 361.29% in 2022.
• Over 5 years, Other financing activities stood at $15000.0 in 2020, then sank by 106.67% to -$1000.0 in 2021, then surged by 8400.0% to $83000.0 in 2022, then tumbled by 185.54% to -$71000.0 in 2023, then jumped by 357.75% to $183000.0 in 2024.
• According to Business Quant data, Other financing activities over the past three periods registered $183000.0, -$71000.0, and $83000.0 for Q1 2024, Q3 2023, and Q4 2022 respectively.